Pre-clinical development of a recombinant, replication- competent adenovirus serotype 4 vector vaccine expressing hiv-1 envelope 1086 clade c

HIGHLIGHTS

• who: Expressing HIV- and colleagues from the PaxVax Inc, San Diego, California, United States of America, UNC Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North have published the research: Pre-Clinical Development of a Recombinant, Replication- Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C, in the Journal: PLOS ONE policies on sharing data and materials. of August/15,/2013
• what: The aim of this study is to build upon two observations. The aim of this study was to evaluate recombinant Ad4 vectors encoding HIV . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.